NPR Top8/7/2026, 10:00:00 AM

Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'

WorldPing

Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.

This is a short WorldPing brief. The full report was published by NPR Top.

Read the full report at NPR Top

Related news

Genius Sports Now Settles Contracts for Both Kalshi and Polymarket

WorldPing

Bitcoin.com

Genius Sports Now Settles Contracts for Both Kalshi and Polymarket

Genius Sports signed official-data, integrity, and marketing agreements with Polymarket on Aug. 4 and Kalshi on Aug. 5, putting one supplier underneath the settlement layer of both rival prediction platforms.

Brief by WorldPing · Original reporting by Bitcoin.com